REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 109 filers reported holding REPLIMUNE GROUP INC in Q2 2021. The put-call ratio across all filers is 4.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287 | -29.3% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $406 | +33.6% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $304 | -35.6% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $472 | -99.8% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $289,000 | -4.6% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $303,000 | +0.7% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $301,000 | -29.5% | 17,700 | +9.9% | 0.00% | 0.0% |
| Q4 2021 | $427,000 | -6.2% | 16,100 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | -24.5% | 15,700 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $603,000 | +23.8% | 15,700 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $487,000 | -23.1% | 15,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $633,000 | – | 15,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,838,968 | $41,619,000 | 21.14% |
| Omega Fund Management, LLC | 5,103,455 | $74,567,000 | 19.02% |
| Foresite Capital Management IV, LLC | 1,228,656 | $18,012,000 | 5.09% |
| Foresite Capital Management III, LLC | 779,656 | $11,430,000 | 3.75% |
| BVF INC/IL | 1,724,609 | $25,283,000 | 2.76% |
| Redmile Group, LLC | 2,197,003 | $32,208,000 | 0.91% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 711,770 | $10,435,000 | 0.41% |
| EMERALD ADVISERS, LLC | 693,178 | $10,162,000 | 0.41% |
| Artal Group S.A. | 600,000 | $8,796,000 | 0.36% |
| Polar Capital LLP | 175,000 | $2,566,000 | 0.02% |